 | • レポートコード：QAF27924 • 出版社/出版日：QYResearch / 2021年4月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のワクチンアジュバント市場について種類別（経口、皮下、筋肉内、その他）、用途別（動物用ワクチンアジュバント（研究用、商業用）、ヒト用ワクチンアジュバント（研究用、商業用））、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ワクチンアジュバント市場の概要 ・世界の主要地域別ワクチンアジュバント市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のワクチンアジュバント市場規模2016-2021：種類別（経口、皮下、筋肉内、その他） ・世界のワクチンアジュバント市場予測2012-2027：種類別（経口、皮下、筋肉内、その他） ・世界のワクチンアジュバント市場規模2016-2021：用途別（動物用ワクチンアジュバント（研究用、商業用）、ヒト用ワクチンアジュバント（研究用、商業用）） ・世界のワクチンアジュバント市場予測2012-2027：用途別（動物用ワクチンアジュバント（研究用、商業用）、ヒト用ワクチンアジュバント（研究用、商業用）） ・ワクチンアジュバントのアメリカ市場規模と予測2016-2021 ・ワクチンアジュバントのヨーロッパ市場規模と予測2016-2021 ・ワクチンアジュバントの中国市場規模と予測2016-2021 ・ワクチンアジュバントの日本市場規模と予測2016-2021 ・ワクチンアジュバントの東南アジア市場規模と予測2016-2021 ・ワクチンアジュバントのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （SEPPIC、SDA BIO、Croda International Plc、SPI Pharma、Phibro Animal Health Corporation、Tj Kaiwei、Novavax、Zhuoyue、Aphios、GSK、CSL Limited、Brenntag Biosector、SEPPIC、SPI Pharma、Novavax、Avanti Polar Lipids、Aphios） ・ワクチンアジュバントの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ワクチンアジュバントの市場動向・機会・課題 ・調査の結論 |
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The classification of vaccine adjuvants includes veterinary vaccine adjuvants and human vaccine adjuvants. And the proportion of human vaccine adjuvants in 2016 is about 52.4%. The veterinary vaccine adjuvants in 2015 are about 47.6%.
The classification of Veterinary Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2016 is about 56.3%. The Subcutaneous in 2016 is about 29%.
The classification of Human Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2016 is about 55.5%. The Subcutaneous in 2016 is about 28.8%.
Market Analysis and Insights: Global Vaccine Adjuvants Market
The global Vaccine Adjuvants market was valued at US$ 839.7 in 2020 and will reach US$ 1503.9 million by the end of 2027, growing at a CAGR of 10.2% during 2022-2027.
Global Vaccine Adjuvants Scope and Market Size
The global Vaccine Adjuvants market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vaccine Adjuvants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Oral
Subcutaneous
Intramuscular
Others
Segment by Application
Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Human Vaccine Adjuvants (Research Applications, Commercial Applications)
The Vaccine Adjuvants market is analysed and market size information is provided by regions (countries). Segment by Application, the Vaccine Adjuvants market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
SEPPIC
SDA BIO
Croda International Plc
SPI Pharma
Phibro Animal Health Corporation
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL Limited
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios
1 Vaccine Adjuvants Market Overview
1.1 Vaccine Adjuvants Product Scope
1.2 Vaccine Adjuvants Segment by Type
1.2.1 Global Vaccine Adjuvants Sales by Type (2016 & 2021 & 2027)
1.2.2 Oral
1.2.3 Subcutaneous
1.2.4 Intramuscular
1.2.5 Others
1.3 Vaccine Adjuvants Segment by Application
1.3.1 Global Vaccine Adjuvants Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
1.3.3 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
1.4 Vaccine Adjuvants Market Estimates and Forecasts (2016-2027)
1.4.1 Global Vaccine Adjuvants Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Vaccine Adjuvants Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Vaccine Adjuvants Price Trends (2016-2027)
2 Vaccine Adjuvants Estimates and Forecasts by Region
2.1 Global Vaccine Adjuvants Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Vaccine Adjuvants Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Vaccine Adjuvants Sales Market Share by Region (2016-2021)
2.2.2 Global Vaccine Adjuvants Revenue Market Share by Region (2016-2021)
2.3 Global Vaccine Adjuvants Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Vaccine Adjuvants Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Vaccine Adjuvants Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Vaccine Adjuvants Estimates and Projections (2016-2027)
2.4.2 Europe Vaccine Adjuvants Estimates and Projections (2016-2027)
2.4.3 China Vaccine Adjuvants Estimates and Projections (2016-2027)
2.4.4 Japan Vaccine Adjuvants Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Vaccine Adjuvants Estimates and Projections (2016-2027)
2.4.6 India Vaccine Adjuvants Estimates and Projections (2016-2027)
3 Global Vaccine Adjuvants Competition Landscape by Players
3.1 Global Top Vaccine Adjuvants Players by Sales (2016-2021)
3.2 Global Top Vaccine Adjuvants Players by Revenue (2016-2021)
3.3 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2020)
3.4 Global Vaccine Adjuvants Average Price by Company (2016-2021)
3.5 Manufacturers Vaccine Adjuvants Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Vaccine Adjuvants Market Size by Type
4.1 Global Vaccine Adjuvants Historic Market Review by Type (2016-2021)
4.1.1 Global Vaccine Adjuvants Sales Market Share by Type (2016-2021)
4.1.2 Global Vaccine Adjuvants Revenue Market Share by Type (2016-2021)
4.1.3 Global Vaccine Adjuvants Price by Type (2016-2021)
4.2 Global Vaccine Adjuvants Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Vaccine Adjuvants Sales Forecast by Type (2022-2027)
4.2.2 Global Vaccine Adjuvants Revenue Forecast by Type (2022-2027)
4.2.3 Global Vaccine Adjuvants Price Forecast by Type (2022-2027)
5 Global Vaccine Adjuvants Market Size by Application
5.1 Global Vaccine Adjuvants Historic Market Review by Application (2016-2021)
5.1.1 Global Vaccine Adjuvants Sales Market Share by Application (2016-2021)
5.1.2 Global Vaccine Adjuvants Revenue Market Share by Application (2016-2021)
5.1.3 Global Vaccine Adjuvants Price by Application (2016-2021)
5.2 Global Vaccine Adjuvants Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Vaccine Adjuvants Sales Forecast by Application (2022-2027)
5.2.2 Global Vaccine Adjuvants Revenue Forecast by Application (2022-2027)
5.2.3 Global Vaccine Adjuvants Price Forecast by Application (2022-2027)
6 North America Vaccine Adjuvants Market Facts & Figures
6.1 North America Vaccine Adjuvants Sales by Company
6.1.1 North America Vaccine Adjuvants Sales by Company (2016-2021)
6.1.2 North America Vaccine Adjuvants Revenue by Company (2016-2021)
6.2 North America Vaccine Adjuvants Sales Breakdown by Type
6.2.1 North America Vaccine Adjuvants Sales Breakdown by Type (2016-2021)
6.2.2 North America Vaccine Adjuvants Sales Breakdown by Type (2022-2027)
6.3 North America Vaccine Adjuvants Sales Breakdown by Application
6.3.1 North America Vaccine Adjuvants Sales Breakdown by Application (2016-2021)
6.3.2 North America Vaccine Adjuvants Sales Breakdown by Application (2022-2027)
7 Europe Vaccine Adjuvants Market Facts & Figures
7.1 Europe Vaccine Adjuvants Sales by Company
7.1.1 Europe Vaccine Adjuvants Sales by Company (2016-2021)
7.1.2 Europe Vaccine Adjuvants Revenue by Company (2016-2021)
7.2 Europe Vaccine Adjuvants Sales Breakdown by Type
7.2.1 Europe Vaccine Adjuvants Sales Breakdown by Type (2016-2021)
7.2.2 Europe Vaccine Adjuvants Sales Breakdown by Type (2022-2027)
7.3 Europe Vaccine Adjuvants Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Vaccine Adjuvants Market Facts & Figures
8.1 China Vaccine Adjuvants Sales by Company
8.1.1 China Vaccine Adjuvants Sales by Company (2016-2021)
8.1.2 China Vaccine Adjuvants Revenue by Company (2016-2021)
8.2 China Vaccine Adjuvants Sales Breakdown by Type
8.2.1 China Vaccine Adjuvants Sales Breakdown by Type (2016-2021)
8.2.2 China Vaccine Adjuvants Sales Breakdown by Type (2022-2027)
8.3 China Vaccine Adjuvants Sales Breakdown by Application
8.3.1 China 312 Sales Breakdown by Application (2016-2021)
8.3.2 China 312 Sales Breakdown by Application (2022-2027)
9 Japan Vaccine Adjuvants Market Facts & Figures
9.1 Japan Vaccine Adjuvants Sales by Company
9.1.1 Japan Vaccine Adjuvants Sales by Company (2016-2021)
9.1.2 Japan Vaccine Adjuvants Revenue by Company (2016-2021)
9.2 Japan Vaccine Adjuvants Sales Breakdown by Type
9.2.1 Japan Vaccine Adjuvants Sales Breakdown by Type (2016-2021)
9.2.2 Japan Vaccine Adjuvants Sales Breakdown by Type (2022-2027)
9.3 Japan Vaccine Adjuvants Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Vaccine Adjuvants Market Facts & Figures
10.1 Southeast Asia Vaccine Adjuvants Sales by Company
10.1.1 Southeast Asia Vaccine Adjuvants Sales by Company (2016-2021)
10.1.2 Southeast Asia Vaccine Adjuvants Revenue by Company (2016-2021)
10.2 Southeast Asia Vaccine Adjuvants Sales Breakdown by Type
10.2.1 Southeast Asia Vaccine Adjuvants Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Vaccine Adjuvants Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Vaccine Adjuvants Sales Breakdown by Application
10.3.1 Southeast Asia Kg Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Kg Sales Breakdown by Application (2022-2027)
11 India Vaccine Adjuvants Market Facts & Figures
11.1 India Vaccine Adjuvants Sales by Company
11.1.1 India Vaccine Adjuvants Sales by Company (2016-2021)
11.1.2 India Vaccine Adjuvants Revenue by Company (2016-2021)
11.2 India Vaccine Adjuvants Sales Breakdown by Type
11.2.1 India Vaccine Adjuvants Sales Breakdown by Type (2016-2021)
11.2.2 India Vaccine Adjuvants Sales Breakdown by Type (2022-2027)
11.3 India Vaccine Adjuvants Sales Breakdown by Application
11.3.1 India Vaccine Adjuvants Sales Breakdown by Application (2016-2021)
11.3.2 India Vaccine Adjuvants Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Vaccine Adjuvants Business
12.1 SEPPIC
12.1.1 SEPPIC Corporation Information
12.1.2 SEPPIC Business Overview
12.1.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.1.4 SEPPIC Vaccine Adjuvants Products Offered
12.1.5 SEPPIC Recent Development
12.2 SDA BIO
12.2.1 SDA BIO Corporation Information
12.2.2 SDA BIO Business Overview
12.2.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.2.4 SDA BIO Vaccine Adjuvants Products Offered
12.2.5 SDA BIO Recent Development
12.3 Croda International Plc
12.3.1 Croda International Plc Corporation Information
12.3.2 Croda International Plc Business Overview
12.3.3 Croda International Plc Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Croda International Plc Vaccine Adjuvants Products Offered
12.3.5 Croda International Plc Recent Development
12.4 SPI Pharma
12.4.1 SPI Pharma Corporation Information
12.4.2 SPI Pharma Business Overview
12.4.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.4.4 SPI Pharma Vaccine Adjuvants Products Offered
12.4.5 SPI Pharma Recent Development
12.5 Phibro Animal Health Corporation
12.5.1 Phibro Animal Health Corporation Corporation Information
12.5.2 Phibro Animal Health Corporation Business Overview
12.5.3 Phibro Animal Health Corporation Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Phibro Animal Health Corporation Vaccine Adjuvants Products Offered
12.5.5 Phibro Animal Health Corporation Recent Development
12.6 Tj Kaiwei
12.6.1 Tj Kaiwei Corporation Information
12.6.2 Tj Kaiwei Business Overview
12.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Tj Kaiwei Vaccine Adjuvants Products Offered
12.6.5 Tj Kaiwei Recent Development
12.7 Novavax
12.7.1 Novavax Corporation Information
12.7.2 Novavax Business Overview
12.7.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Novavax Vaccine Adjuvants Products Offered
12.7.5 Novavax Recent Development
12.8 Zhuoyue
12.8.1 Zhuoyue Corporation Information
12.8.2 Zhuoyue Business Overview
12.8.3 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Zhuoyue Vaccine Adjuvants Products Offered
12.8.5 Zhuoyue Recent Development
12.9 Aphios
12.9.1 Aphios Corporation Information
12.9.2 Aphios Business Overview
12.9.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Aphios Vaccine Adjuvants Products Offered
12.9.5 Aphios Recent Development
12.10 GSK
12.10.1 GSK Corporation Information
12.10.2 GSK Business Overview
12.10.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.10.4 GSK Vaccine Adjuvants Products Offered
12.10.5 GSK Recent Development
12.11 CSL Limited
12.11.1 CSL Limited Corporation Information
12.11.2 CSL Limited Business Overview
12.11.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.11.4 CSL Limited Vaccine Adjuvants Products Offered
12.11.5 CSL Limited Recent Development
12.12 Brenntag Biosector
12.12.1 Brenntag Biosector Corporation Information
12.12.2 Brenntag Biosector Business Overview
12.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Brenntag Biosector Vaccine Adjuvants Products Offered
12.12.5 Brenntag Biosector Recent Development
12.13 SEPPIC
12.13.1 SEPPIC Corporation Information
12.13.2 SEPPIC Business Overview
12.13.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.13.4 SEPPIC Vaccine Adjuvants Products Offered
12.13.5 SEPPIC Recent Development
12.14 SPI Pharma
12.14.1 SPI Pharma Corporation Information
12.14.2 SPI Pharma Business Overview
12.14.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.14.4 SPI Pharma Vaccine Adjuvants Products Offered
12.14.5 SPI Pharma Recent Development
12.15 Novavax
12.15.1 Novavax Corporation Information
12.15.2 Novavax Business Overview
12.15.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Novavax Vaccine Adjuvants Products Offered
12.15.5 Novavax Recent Development
12.16 Avanti Polar Lipids
12.16.1 Avanti Polar Lipids Corporation Information
12.16.2 Avanti Polar Lipids Business Overview
12.16.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Avanti Polar Lipids Vaccine Adjuvants Products Offered
12.16.5 Avanti Polar Lipids Recent Development
12.17 Aphios
12.17.1 Aphios Corporation Information
12.17.2 Aphios Business Overview
12.17.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Aphios Vaccine Adjuvants Products Offered
12.17.5 Aphios Recent Development
13 Vaccine Adjuvants Manufacturing Cost Analysis
13.1 Vaccine Adjuvants Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Vaccine Adjuvants
13.4 Vaccine Adjuvants Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Vaccine Adjuvants Distributors List
14.3 Vaccine Adjuvants Customers
15 Market Dynamics
15.1 Vaccine Adjuvants Market Trends
15.2 Vaccine Adjuvants Drivers
15.3 Vaccine Adjuvants Market Challenges
15.4 Vaccine Adjuvants Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Vaccine Adjuvants Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Vaccine Adjuvants Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Vaccine Adjuvants Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Vaccine Adjuvants Sales (Kg) by Region (2016-2021)
Table 5. Global Vaccine Adjuvants Sales Market Share by Region (2016-2021)
Table 6. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Vaccine Adjuvants Revenue Share by Region (2016-2021)
Table 8. Global Vaccine Adjuvants Sales (Kg) Forecast by Region (2022-2027)
Table 9. Global Vaccine Adjuvants Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Vaccine Adjuvants Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Vaccine Adjuvants Revenue Share Forecast by Region (2022-2027)
Table 12. Global Vaccine Adjuvants Sales (Kg) of Key Companies (2016-2021)
Table 13. Global Vaccine Adjuvants Sales Share by Company (2016-2021)
Table 14. Global Vaccine Adjuvants Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Vaccine Adjuvants Revenue Share by Company (2016-2021)
Table 16. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine Adjuvants as of 2020)
Table 17. Global Vaccine Adjuvants Average Price (USD/Kg) of Key Company (2016-2021)
Table 18. Manufacturers Vaccine Adjuvants Manufacturing Sites and Area Served
Table 19. Manufacturers Vaccine Adjuvants Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Vaccine Adjuvants Sales (Kg) by Type (2016-2021)
Table 22. Global Vaccine Adjuvants Sales Share by Type (2016-2021)
Table 23. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Vaccine Adjuvants Price (USD/Kg) by Type (2016-2021)
Table 25. Global Vaccine Adjuvants Sales Share by Type (2022-2027)
Table 26. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Vaccine Adjuvants Revenue Share by Type (2022-2027)
Table 28. Global Vaccine Adjuvants Price (USD/Kg) by Type (2022-2027)
Table 29. Global Vaccine Adjuvants Sales (Kg) by Application (2016-2021)
Table 30. Global Vaccine Adjuvants Sales Share by Application (2016-2021)
Table 31. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Vaccine Adjuvants Price (USD/Kg) by Application (2016-2021)
Table 33. Global Vaccine Adjuvants Sales (Kg) by Application (2022-2027)
Table 34. Global Vaccine Adjuvants Sales Share by Application (2022-2027)
Table 35. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Vaccine Adjuvants Revenue Share by Application (2022-2027)
Table 37. Global Vaccine Adjuvants Price (USD/Kg) by Application (2022-2027)
Table 38. North America Vaccine Adjuvants Sales (Kg) by Company (2016-2021)
Table 39. North America Vaccine Adjuvants Sales Market Share by Company (2016-2021)
Table 40. North America Vaccine Adjuvants Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Vaccine Adjuvants Revenue Market Share by Company (2016-2021)
Table 42. North America Vaccine Adjuvants Sales by Type (2016-2021) & (Kg)
Table 43. North America Vaccine Adjuvants Sales Market Share by Type (2016-2021)
Table 44. North America Vaccine Adjuvants Sales by Type (2022-2027) & (Kg)
Table 45. North America Vaccine Adjuvants Sales Market Share by Type (2022-2027)
Table 46. North America Vaccine Adjuvants Sales by Application (2016-2021) & (Kg)
Table 47. North America Vaccine Adjuvants Sales Market Share by Application (2016-2021)
Table 48. North America Vaccine Adjuvants Sales by Application (2022-2027) & (Kg)
Table 49. North America Vaccine Adjuvants Sales Market Share by Application (2022-2027)
Table 50. Europe Vaccine Adjuvants Sales (Kg) by Company (2016-2021)
Table 51. Europe Vaccine Adjuvants Sales Market Share by Company (2016-2021)
Table 52. Europe Vaccine Adjuvants Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Vaccine Adjuvants Revenue Market Share by Company (2016-2021)
Table 54. Europe Vaccine Adjuvants Sales by Type (2016-2021) & (Kg)
Table 55. Europe Vaccine Adjuvants Sales Market Share by Type (2016-2021)
Table 56. Europe Vaccine Adjuvants Sales by Type (2022-2027) & (Kg)
Table 57. Europe Vaccine Adjuvants Sales Market Share by Type (2022-2027)
Table 58. Europe Vaccine Adjuvants Sales by Application (2016-2021) & (Kg)
Table 59. Europe Vaccine Adjuvants Sales Market Share by Application (2016-2021)
Table 60. Europe Vaccine Adjuvants Sales by Application (2022-2027) & (Kg)
Table 61. Europe Vaccine Adjuvants Sales Market Share by Application (2022-2027)
Table 62. China Vaccine Adjuvants Sales (Kg) by Company (2016-2021)
Table 63. China Vaccine Adjuvants Sales Market Share by Company (2016-2021)
Table 64. China Vaccine Adjuvants Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Vaccine Adjuvants Revenue Market Share by Company (2016-2021)
Table 66. China Vaccine Adjuvants Sales by Type (2016-2021) & (Kg)
Table 67. China Vaccine Adjuvants Sales Market Share by Type (2016-2021)
Table 68. China Vaccine Adjuvants Sales by Type (2022-2027) & (Kg)
Table 69. China Vaccine Adjuvants Sales Market Share by Type (2022-2027)
Table 70. China Vaccine Adjuvants Sales by Application (2016-2021) & (Kg)
Table 71. China Vaccine Adjuvants Sales Market Share by Application (2016-2021)
Table 72. China Vaccine Adjuvants Sales by Application (2022-2027) & (Kg)
Table 73. China Vaccine Adjuvants Sales Market Share by Application (2022-2027)
Table 74. Japan Vaccine Adjuvants Sales (Kg) by Company (2016-2021)
Table 75. Japan Vaccine Adjuvants Sales Market Share by Company (2016-2021)
Table 76. Japan Vaccine Adjuvants Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Vaccine Adjuvants Revenue Market Share by Company (2016-2021)
Table 78. Japan Vaccine Adjuvants Sales by Type (2016-2021) & (Kg)
Table 79. Japan Vaccine Adjuvants Sales Market Share by Type (2016-2021)
Table 80. Japan Vaccine Adjuvants Sales by Type (2022-2027) & (Kg)
Table 81. Japan Vaccine Adjuvants Sales Market Share by Type (2022-2027)
Table 82. Japan Vaccine Adjuvants Sales by Application (2016-2021) & (Kg)
Table 83. Japan Vaccine Adjuvants Sales Market Share by Application (2016-2021)
Table 84. Japan Vaccine Adjuvants Sales by Application (2022-2027) & (Kg)
Table 85. Japan Vaccine Adjuvants Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Vaccine Adjuvants Sales (Kg) by Company (2016-2021)
Table 87. Southeast Asia Vaccine Adjuvants Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Vaccine Adjuvants Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Vaccine Adjuvants Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Vaccine Adjuvants Sales by Type (2016-2021) & (Kg)
Table 91. Southeast Asia Vaccine Adjuvants Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Vaccine Adjuvants Sales by Type (2022-2027) & (Kg)
Table 93. Southeast Asia Vaccine Adjuvants Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Vaccine Adjuvants Sales by Application (2016-2021) & (Kg)
Table 95. Southeast Asia Vaccine Adjuvants Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Vaccine Adjuvants Sales by Application (2022-2027) & (Kg)
Table 97. Southeast Asia Vaccine Adjuvants Sales Market Share by Application (2022-2027)
Table 98. India Vaccine Adjuvants Sales (Kg) by Company (2016-2021)
Table 99. India Vaccine Adjuvants Sales Market Share by Company (2016-2021)
Table 100. India Vaccine Adjuvants Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Vaccine Adjuvants Revenue Market Share by Company (2016-2021)
Table 102. India Vaccine Adjuvants Sales by Type (2016-2021) & (Kg)
Table 103. India Vaccine Adjuvants Sales Market Share by Type (2016-2021)
Table 104. India Vaccine Adjuvants Sales by Type (2022-2027) & (Kg)
Table 105. India Vaccine Adjuvants Sales Market Share by Type (2022-2027)
Table 106. India Vaccine Adjuvants Sales by Application (2016-2021) & (Kg)
Table 107. India Vaccine Adjuvants Sales Market Share by Application (2016-2021)
Table 108. India Vaccine Adjuvants Sales by Application (2022-2027) & (Kg)
Table 109. India Vaccine Adjuvants Sales Market Share by Application (2022-2027)
Table 110. SEPPIC Corporation Information
Table 111. SEPPIC Description and Business Overview
Table 112. SEPPIC Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. SEPPIC Vaccine Adjuvants Product
Table 114. SEPPIC Recent Development
Table 115. SDA BIO Corporation Information
Table 116. SDA BIO Description and Business Overview
Table 117. SDA BIO Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. SDA BIO Vaccine Adjuvants Product
Table 119. SDA BIO Recent Development
Table 120. Croda International Plc Corporation Information
Table 121. Croda International Plc Description and Business Overview
Table 122. Croda International Plc Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Croda International Plc Vaccine Adjuvants Product
Table 124. Croda International Plc Recent Development
Table 125. SPI Pharma Corporation Information
Table 126. SPI Pharma Description and Business Overview
Table 127. SPI Pharma Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. SPI Pharma Vaccine Adjuvants Product
Table 129. SPI Pharma Recent Development
Table 130. Phibro Animal Health Corporation Corporation Information
Table 131. Phibro Animal Health Corporation Description and Business Overview
Table 132. Phibro Animal Health Corporation Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. Phibro Animal Health Corporation Vaccine Adjuvants Product
Table 134. Phibro Animal Health Corporation Recent Development
Table 135. Tj Kaiwei Corporation Information
Table 136. Tj Kaiwei Description and Business Overview
Table 137. Tj Kaiwei Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. Tj Kaiwei Vaccine Adjuvants Product
Table 139. Tj Kaiwei Recent Development
Table 140. Novavax Corporation Information
Table 141. Novavax Description and Business Overview
Table 142. Novavax Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. Novavax Vaccine Adjuvants Product
Table 144. Novavax Recent Development
Table 145. Zhuoyue Corporation Information
Table 146. Zhuoyue Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 147. Zhuoyue Description and Business Overview
Table 148. Zhuoyue Vaccine Adjuvants Product
Table 149. Zhuoyue Recent Development
Table 150. Aphios Corporation Information
Table 151. Aphios Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 152. Aphios Description and Business Overview
Table 153. Aphios Vaccine Adjuvants Product
Table 154. Aphios Recent Development
Table 155. GSK Corporation Information
Table 156. GSK Description and Business Overview
Table 157. GSK Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 158. GSK Vaccine Adjuvants Product
Table 159. GSK Recent Development
Table 160. CSL Limited Corporation Information
Table 161. CSL Limited Description and Business Overview
Table 162. CSL Limited Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 163. CSL Limited Vaccine Adjuvants Product
Table 164. CSL Limited Recent Development
Table 165. Brenntag Biosector Corporation Information
Table 166. Brenntag Biosector Description and Business Overview
Table 167. Brenntag Biosector Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 168. Brenntag Biosector Vaccine Adjuvants Product
Table 169. Brenntag Biosector Recent Development
Table 170. SEPPIC Corporation Information
Table 171. SEPPIC Description and Business Overview
Table 172. SEPPIC Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 173. SEPPIC Vaccine Adjuvants Product
Table 174. SEPPIC Recent Development
Table 175. SPI Pharma Corporation Information
Table 176. SPI Pharma Description and Business Overview
Table 177. SPI Pharma Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 178. SPI Pharma Vaccine Adjuvants Product
Table 179. SPI Pharma Recent Development
Table 180. Novavax Corporation Information
Table 181. Novavax Description and Business Overview
Table 182. Novavax Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 183. Novavax Vaccine Adjuvants Product
Table 184. Novavax Recent Development
Table 185. Avanti Polar Lipids Corporation Information
Table 186. Avanti Polar Lipids Description and Business Overview
Table 187. Avanti Polar Lipids Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 188. Avanti Polar Lipids Vaccine Adjuvants Product
Table 189. Avanti Polar Lipids Recent Development
Table 190. Aphios Corporation Information
Table 191. Aphios Description and Business Overview
Table 192. Aphios Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 193. Aphios Vaccine Adjuvants Product
Table 194. Aphios Recent Development
Table 195. Production Base and Market Concentration Rate of Raw Material
Table 196. Key Suppliers of Raw Materials
Table 197. Vaccine Adjuvants Distributors List
Table 198. Vaccine Adjuvants Customers List
Table 199. Vaccine Adjuvants Market Trends
Table 200. Vaccine Adjuvants Market Drivers
Table 201. Vaccine Adjuvants Market Challenges
Table 202. Vaccine Adjuvants Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccine Adjuvants Product Picture
Figure 2. Global Vaccine Adjuvants Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Vaccine Adjuvants Sales Market Share by Application in 2021 & 2027
Figure 6. Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Examples
Figure 7. Human Vaccine Adjuvants (Research Applications, Commercial Applications) Examples
Figure 8. Global Vaccine Adjuvants Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Vaccine Adjuvants Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Vaccine Adjuvants Sales (Kg) Growth Rate (2016-2027)
Figure 11. Global Vaccine Adjuvants Price Trends Growth Rate (2016-2027) (USD/Kg)
Figure 12. Global Vaccine Adjuvants Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Vaccine Adjuvants Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Vaccine Adjuvants Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Vaccine Adjuvants Sales (Kg) Growth Rate (2016-2027)
Figure 16. Europe Vaccine Adjuvants Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Vaccine Adjuvants Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Vaccine Adjuvants Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Vaccine Adjuvants Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Vaccine Adjuvants Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Vaccine Adjuvants Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Vaccine Adjuvants Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Vaccine Adjuvants Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Vaccine Adjuvants Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Vaccine Adjuvants Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Vaccine Adjuvants Players Market Share by Revenue in Vaccine Adjuvants: 2016 & 2020
Figure 27. Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Vaccine Adjuvants Revenue Share by Type (2016-2021)
Figure 29. Global Vaccine Adjuvants Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Vaccine Adjuvants Revenue Share by Application (2016-2021)
Figure 31. Global Vaccine Adjuvants Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Vaccine Adjuvants Sales Market Share by Type in 2020
Figure 33. North America Vaccine Adjuvants Sales Market Share by Application in 2020
Figure 34. Europe Vaccine Adjuvants Sales Market Share by Type in 2020
Figure 35. Europe Vaccine Adjuvants Sales Market Share by Application in 2020
Figure 36. China Vaccine Adjuvants Sales Market Share by Type in 2020
Figure 37. China Vaccine Adjuvants Sales Market Share by Application in 2020
Figure 38. Japan Vaccine Adjuvants Sales Market Share by Type in 2020
Figure 39. Japan Vaccine Adjuvants Sales Market Share by Application in 2020
Figure 40. Southeast Asia Vaccine Adjuvants Sales Market Share by Type in 2020
Figure 41. Southeast Asia Vaccine Adjuvants Sales Market Share by Application in 2020
Figure 42. India Vaccine Adjuvants Sales Market Share by Type in 2020
Figure 43. India Vaccine Adjuvants Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Vaccine Adjuvants
Figure 46. Manufacturing Process Analysis of Vaccine Adjuvants
Figure 47. Vaccine Adjuvants Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
動物用ワクチンアジュバントのグローバル市場2021 An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vacci…- 世界の免疫賦活性アジュバント産業調査2019-2025 Adjuvant is an integral part of a vaccine that helps to develop strong immune response in the human body. Conventional vaccines are derived from toxin, inactivated whole organism, and live-attenuated, which are effective in stimulating antibody-based immunity. Adjuvants are used to enhance efficienc…
- 世界の免疫賦活性アジュバント産業調査2019-2025 Adjuvant is an integral part of a vaccine that helps to develop strong immune response in the human body. Conventional vaccines are derived from toxin, inactivated whole organism, and live-attenuated, which are effective in stimulating antibody-based immunity. Adjuvants are used to enhance efficienc…
- 農業用アジュバントのグローバル市場調査 2019年 The global Agricultural Adjuvants market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Agricultural Adjuvants volume and value at global level, regional level and company level. From a global perspective…
- 世界の髄膜炎菌感染症ワクチン市場規模・現状・予測（2021年-2027年） Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.Different versions are effective against some or all of the following types of meningococcus: A, C, W-135,and Y.The vaccines are between 85 and 100% effective for at least two years.They result in…